185 related articles for article (PubMed ID: 15340013)
1. The RacGEF Tiam1 inhibits migration and invasion of metastatic melanoma via a novel adhesive mechanism.
Uhlenbrock K; Eberth A; Herbrand U; Daryab N; Stege P; Meier F; Friedl P; Collard JG; Ahmadian MR
J Cell Sci; 2004 Sep; 117(Pt 20):4863-71. PubMed ID: 15340013
[TBL] [Abstract][Full Text] [Related]
2. The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression.
Minard ME; Kim LS; Price JE; Gallick GE
Breast Cancer Res Treat; 2004 Mar; 84(1):21-32. PubMed ID: 14999151
[TBL] [Abstract][Full Text] [Related]
3. A role for Rac in Tiam1-induced membrane ruffling and invasion.
Michiels F; Habets GG; Stam JC; van der Kammen RA; Collard JG
Nature; 1995 May; 375(6529):338-40. PubMed ID: 7753201
[TBL] [Abstract][Full Text] [Related]
4. The Rac activator Tiam1 is required for (alpha)3(beta)1-mediated laminin-5 deposition, cell spreading, and cell migration.
Hamelers IH; Olivo C; Mertens AE; Pegtel DM; van der Kammen RA; Sonnenberg A; Collard JG
J Cell Biol; 2005 Dec; 171(5):871-81. PubMed ID: 16330714
[TBL] [Abstract][Full Text] [Related]
5. Rho-like GTPases: their role in cell adhesion and invasion.
Michiels F; Collard JG
Biochem Soc Symp; 1999; 65():125-46. PubMed ID: 10320937
[TBL] [Abstract][Full Text] [Related]
6. DOCK10-mediated Cdc42 activation is necessary for amoeboid invasion of melanoma cells.
Gadea G; Sanz-Moreno V; Self A; Godi A; Marshall CJ
Curr Biol; 2008 Oct; 18(19):1456-65. PubMed ID: 18835169
[TBL] [Abstract][Full Text] [Related]
7. Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration?
Swart GW; Lunter PC; Kilsdonk JW; Kempen LC
Cancer Metastasis Rev; 2005 Jun; 24(2):223-36. PubMed ID: 15986133
[TBL] [Abstract][Full Text] [Related]
8. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW
Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule.
van Kilsdonk JW; Wilting RH; Bergers M; van Muijen GN; Schalkwijk J; van Kempen LC; Swart GW
Cancer Res; 2008 May; 68(10):3671-9. PubMed ID: 18483249
[TBL] [Abstract][Full Text] [Related]
10. The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model.
Minard ME; Herynk MH; Collard JG; Gallick GE
Oncogene; 2005 Apr; 24(15):2568-73. PubMed ID: 15735692
[TBL] [Abstract][Full Text] [Related]
11. Rho GTPases: signaling, migration, and invasion.
Schmitz AA; Govek EE; Böttner B; Van Aelst L
Exp Cell Res; 2000 Nov; 261(1):1-12. PubMed ID: 11082269
[TBL] [Abstract][Full Text] [Related]
12. Expressions of Rac1, Tiam1 and Cdc42 in retinoblastoma.
Adithi M; Venkatesan N; Kandalam M; Biswas J; Krishnakumar S
Exp Eye Res; 2006 Dec; 83(6):1446-52. PubMed ID: 17027002
[TBL] [Abstract][Full Text] [Related]
13. Rac upregulates tissue inhibitor of metalloproteinase-1 expression by redox-dependent activation of extracellular signal-regulated kinase signaling.
Engers R; Springer E; Kehren V; Simic T; Young DA; Beier J; Klotz LO; Clark IM; Sies H; Gabbert HE
FEBS J; 2006 Oct; 273(20):4754-69. PubMed ID: 16984397
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.
Yamazaki D; Kurisu S; Takenawa T
Oncogene; 2009 Apr; 28(13):1570-83. PubMed ID: 19234490
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-2 regulates cell migration in colon cancer cells through Tiam1-mediated Rac activation.
Choi Y; Kim H; Chung H; Hwang JS; Shin JA; Han IO; Oh ES
Biochem Biophys Res Commun; 2010 Jan; 391(1):921-5. PubMed ID: 19962968
[TBL] [Abstract][Full Text] [Related]
16. SRC-induced disassembly of adherens junctions requires localized phosphorylation and degradation of the rac activator tiam1.
Woodcock SA; Rooney C; Liontos M; Connolly Y; Zoumpourlis V; Whetton AD; Gorgoulis VG; Malliri A
Mol Cell; 2009 Mar; 33(5):639-53. PubMed ID: 19285946
[TBL] [Abstract][Full Text] [Related]
17. MEK/ERK regulates adherens junctions and migration through Rac1.
Ray RM; Vaidya RJ; Johnson LR
Cell Motil Cytoskeleton; 2007 Mar; 64(3):143-56. PubMed ID: 17183546
[TBL] [Abstract][Full Text] [Related]
18. Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion.
Patel V; Rosenfeldt HM; Lyons R; Servitja JM; Bustelo XR; Siroff M; Gutkind JS
Carcinogenesis; 2007 Jun; 28(6):1145-52. PubMed ID: 17234718
[TBL] [Abstract][Full Text] [Related]
19. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule).
Degen WG; van Kempen LC; Gijzen EG; van Groningen JJ; van Kooyk Y; Bloemers HP; Swart GW
Am J Pathol; 1998 Mar; 152(3):805-13. PubMed ID: 9502422
[TBL] [Abstract][Full Text] [Related]
20. 16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway.
Lee SH; Kunz J; Lin SH; Yu-Lee LY
Cancer Res; 2007 Nov; 67(22):11045-53. PubMed ID: 18006851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
